Dianthus shareholders approve 2.93M share increase to stock option plan

Dianthus Therapeutics, Inc. /DE/

Stockholders approved an amendment increasing shares reserved under the stock option plan by 2,931,820 shares.
Evergreen provision raised from 4% to 5% of outstanding shares annually through 2028; plan expiration extended to March 14, 2034.
Class III directors Leon O. Moulder Jr. and Alison F. Lawton elected; advisory votes on executive compensation approved with 23.0M votes for, 26.8K against.
Stockholders ratified Deloitte as independent auditor for FY2024 with 24.1M votes for.
Advisory vote on executive compensation frequency set to every year based on 23.0M votes for one-year interval.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.